SEPT3 as a Potential Molecular Target of Triple-Negative Breast Cancer

References

• Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(6):691–722. doi:10.6004/jnccn.2022.0030
   PubMed Web of Science ®Google Scholar
• Diana A, Carlino F, Franzese E, et al. Early triple negative breast cancer: conventional treatment and emerging therapeutic landscapes. Cancers. 2020;12(4):819. doi:10.3390/cancers12040819
   PubMed Web of Science ®Google Scholar
• Kim C, Gao R, Sei E, et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell. 2018;173(4):879–893.e13. doi:10.1016/j.cell.2018.03.041
   PubMed Web of Science ®Google Scholar
• Mostowy S, Cossart P. Septins: the fourth component of the cytoskeleton. Nat Rev Mol Cell Biol. 2012;13(3):183–194. doi:10.1038/nrm3284
   PubMed Web of Science ®Google Scholar
• Spiliotis ET, Kesisova IA. Spatial regulation of microtubule-dependent transport by septin GTPases. Trends Cell Biol. 2021;31(12):979–993. doi:10.1016/j.tcb.2021.06.004
   PubMed Web of Science ®Google Scholar
• Montagna C, Lyu MS, Hunter K, et al. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 2003;63(9):2179–2187.
   PubMed Web of Science ®Google Scholar
• Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 2011;9(1):133. doi:10.1186/1741-7015-9-133
   PubMedGoogle Scholar
• Farrugia AJ, Rodríguez J, Orgaz HL, et al. CDC42EP5/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion. J Cell Biol. 2020;219(9). doi:10.1083/jcb.201912159
   PubMed Web of Science ®Google Scholar
• Calvo F, Ranftl R, Hooper S, et al. Cdc42EP3/BORG2 and septin network enables mechano-transduction and the emergence of cancer-associated fibroblasts. Cell Rep. 2015;13(12):2699–2714. doi:10.1016/j.celrep.2015.11.052
   PubMed Web of Science ®Google Scholar
• Xue J, Tsang CW, Gai WP, et al. Septin 3 (G-septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminals. J Neurochem. 2004;91(3):579–590. doi:10.1111/j.1471-4159.2004.02755.x
   PubMed Web of Science ®Google Scholar
• Tsang CW, Fedchyshyn M, Harrison J, et al. Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. Mol Cell Biol. 2008;28(23):7012–7029. doi:10.1128/MCB.00035-08
   PubMed Web of Science ®Google Scholar
• Tsang CW, Estey MP, Diciccio JE, et al. Characterization of presynaptic septin complexes in mammalian hippocampal neurons. Biol Chem. 2011;392(8–9):739–749. doi:10.1515/BC.2011.077
   PubMed Web of Science ®Google Scholar
• Fujishima K, Kiyonari H, Kurisu J, et al. Targeted disruption of Sept3, a heteromeric assembly partner of Sept5 and Sept7 in axons, has no effect on developing CNS neurons. J Neurochem. 2007;102(1):77–92. doi:10.1111/j.1471-4159.2007.04478.x
   PubMed Web of Science ®Google Scholar
• Tóth V, Vadászi H, Ravasz L, et al. Neuronal-specific septin-3 binds Atg8/LC3B, accumulates and localizes to autophagosomes during induced autophagy. Cell Mol Life Sci. 2022;79(9):471. doi:10.1007/s00018-022-04488-8
   PubMed Web of Science ®Google Scholar
• Bianchini G, De Angelis C, Licata L, et al. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19(2):91–113. doi:10.1038/s41571-021-00565-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu S, Zhu X, et al. LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis. J Exp Med. 2020;217(3). doi:10.1084/jem.20190950
   Web of Science ®Google Scholar
• Guo B, Wu S, Zhu X, et al. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression. EMBO j. 2020;39(1):e102190. doi:10.15252/embj.2019102190
   PubMed Web of Science ®Google Scholar
• Acharya S, Yao J, Li P, et al. Sphingosine kinase 1 signaling promotes metastasis of triple-negative breast cancer. Cancer Res. 2019;79(16):4211–4226. doi:10.1158/0008-5472.CAN-18-3803
   PubMed Web of Science ®Google Scholar
• Zamberlan M, Boeckx A, Muller F, et al. Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. J Exp Clin Cancer Res. 2022;41(1):95. doi:10.1186/s13046-022-02304-6
   PubMed Web of Science ®Google Scholar
• Györffy BA, Tóth V, Török G, et al. Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer’s disease animal model. Cell Mol Life Sci. 2020;77(24):5243–5258. doi:10.1007/s00018-020-03468-0
   PubMed Web of Science ®Google Scholar
• Musunuri S, Wetterhall M, Ingelsson M, et al. Quantification of the brain proteome in Alzheimer’s disease using multiplexed mass spectrometry. J Proteome Res. 2014;13(4):2056–2068. doi:10.1021/pr401202d
   PubMed Web of Science ®Google Scholar
• Kim DS, Hubbard SL, Peraud A, et al. Analysis of mammalian septin expression in human malignant brain tumors. Neoplasia. 2004;6(2):168–178. doi:10.1593/neo.03310
   PubMed Web of Science ®Google Scholar
• Zhang G, Feng W, Wu J. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT). Biomed Pharmacother. 2020;125:109768. doi:10.1016/j.biopha.2019.109768
   PubMed Web of Science ®Google Scholar
• Zubkova E, Evtushenko E, Beloglazova I, et al. Analysis of MicroRNA profile alterations in extracellular vesicles from mesenchymal stromal cells overexpressing stem cell factor. Front Cell Dev Biol. 2021;9:754025. doi:10.3389/fcell.2021.754025
   PubMed Web of Science ®Google Scholar
• Xu D, Liu A, Wang X, et al. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells. Cell Death Dis. 2018;9(5):514. doi:10.1038/s41419-018-0547-4
   PubMed Web of Science ®Google Scholar
• Poüs C, Klipfel L, Baillet A. Cancer-related functions and subcellular localizations of septins. Front Cell Dev Biol. 2016;4:126. doi:10.3389/fcell.2016.00126
   PubMed Web of Science ®Google Scholar